Last data update: Mar 07, 2021 . (Total: 22400 Documents since 2020)
Records 1-20 (of 20 Record(s))
Query Trace: Lung Adenocarcinoma[original query]
- COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
Katopodis Periklis, et al. International journal of molecular medicine 2021 4 0. (4)
- Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.
Cotroneo Chiara E, et al. European journal of human genetics : EJHG 2021 3 0.
- Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.
Cheng Li-Chin, et al. Medicine 2021 2 0. (7) e24321
- Evaluation of the Susceptibility and Fatality of Lung Cancer Patients towards the COVID-19 Infection: A Systemic Approach through Analyzing the ACE2, CXCL10 and their Co-expressed Genes.
Mahmood Tousif Bin, et al. Current research in microbial sciences 2021 2 0. 100022
- Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
Chen Fengju, et al. Scientific reports 2021 1 0. (1) 2459
- Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro .
Stone Nathan E, et al. mBio 2021 0 0. (1)
- Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.
Chen Long, et al. Aging 2021 1 0.
- Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
Uddin Md Nazim, et al. Chemico-biological interactions 2021 1 0. 109370
- CSF3 Is a Potential Drug Target for the Treatment of COVID-19.
Fang Chao, et al. Frontiers in physiology 2020 0 0. 605792
- Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19.
Hoang Tung, et al. Cancer research and treatment : official journal of Korean Cancer Association 2020 12 0.
- Expression and clinical significance of SARS-CoV-2 human targets in neoplastic and non-neoplastic lung tissues.
Subbarayan Karthikeyan, et al. Current cancer drug targets 2020 12 0.
- The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients.
Tang Bufu, et al. Frontiers in cell and developmental biology 2020 0 0. 577032
- Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai Yu-Jun, et al. International journal of biological sciences 2020 0 0. (15) 3028-3036
- The Potential Effect of the Angiotensin-Converting Enzyme 2 (ACE2) Receptor of 2019-nCoV in Lung Adenocarcinoma Patients on Age
Huo, Qin et al. Research Square September 22 2020
- Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis.
Samad Abdus, et al. Genomics 2020 9 0.
- Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity.
Martino Cameron, et al. bioRxiv : the preprint server for biology 2020 8 0.
- Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
Li Yunjin, et al. Journal of cellular and molecular medicine 2020 7 0.
- Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer.
Sagkan Rahsan Ilikci, et al. Journal of medical virology 2020 6 0.
- Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.
Chai Peiwei, et al. Journal of hematology & oncology 2020 5 0. (1) 43
- Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection.
Kong Qi, et al. Molecular cancer 2020 4 0. (1) 80
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.